CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: IMMUNOHEMATOLOGY MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Analyzers And Systems
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Reagents
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: IMMUNOHEMATOLOGY MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Blood-related Diseases
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. HIV
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: IMMUNOHEMATOLOGY MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Diagnostic Laboratories
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: IMMUNOHEMATOLOGY MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Immunohematology Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Immunohematology Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Immunohematology Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Immunohematology Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Immunohematology Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Immunohematology Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Immunohematology Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Immunohematology Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Immunohematology Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Immunohematology Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Immunohematology Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Immunohematology Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. Australia Immunohematology Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Immunohematology Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Immunohematology Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Immunohematology Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Immunohematology Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Immunohematology Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Immunohematology Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Bio-Rad Laboratories, Inc
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Werfen
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Grifols, S.A.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Danaher Corporation
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Siemens
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Thermo Fisher Scientific Inc.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Abbott Laboratories
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Merck KGaA
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. F. Hoffmann-La Roche Ltd
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Cardinal Health
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. IMMUNOHEMATOLOGY MARKET FOR ANALYZERS AND SYSTEMS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. IMMUNOHEMATOLOGY MARKET FOR REAGENTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 5. IMMUNOHEMATOLOGY MARKET FOR BLOOD-RELATED DISEASES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. IMMUNOHEMATOLOGY MARKET FOR HIV, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. IMMUNOHEMATOLOGY MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. GLOBAL IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 9. IMMUNOHEMATOLOGY MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. IMMUNOHEMATOLOGY MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. IMMUNOHEMATOLOGY MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. IMMUNOHEMATOLOGY MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 17. U.S. IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 18. U.S. IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 19. U.S. IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 20. CANADA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 21. CANADA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 22. CANADA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 23. MEXICO IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 24. MEXICO IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 25. MEXICO IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 26. EUROPE IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 27. EUROPE IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 28. EUROPE IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 29. EUROPE IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 30. GERMANY IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 31. GERMANY IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 32. GERMANY IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. FRANCE IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 34. FRANCE IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 35. FRANCE IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 36. UK IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 37. UK IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 38. UK IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 39. ITALY IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 40. ITALY IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 41. ITALY IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 42. SPAIN IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 43. SPAIN IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 44. SPAIN IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. REST OF EUROPE IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 46. REST OF EUROPE IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 47. REST OF EUROPE IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 48. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 49. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 50. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 51. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 52. JAPAN IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 53. JAPAN IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 54. JAPAN IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 55. CHINA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 56. CHINA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 57. CHINA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. INDIA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 59. INDIA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 60. INDIA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 61. AUSTRALIA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 62. AUSTRALIA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 63. AUSTRALIA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 64. SOUTH KOREA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 65. SOUTH KOREA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 66. SOUTH KOREA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 67. REST OF ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 68. REST OF ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 69. REST OF ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 70. LAMEA IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 71. LAMEA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 72. LAMEA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 73. LAMEA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 74. BRAZIL IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 75. BRAZIL IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 76. BRAZIL IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 77. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 78. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 79. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 80. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 81. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 82. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 83. REST OF LAMEA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 84. REST OF LAMEA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 85. REST OF LAMEA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 86. BIO-RAD LABORATORIES, INC: KEY EXECUTIVES
TABLE 87. BIO-RAD LABORATORIES, INC: COMPANY SNAPSHOT
TABLE 88. BIO-RAD LABORATORIES, INC: OPERATING SEGMENTS
TABLE 89. BIO-RAD LABORATORIES, INC: PRODUCT PORTFOLIO
TABLE 90. BIO-RAD LABORATORIES, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 91. WERFEN : KEY EXECUTIVES
TABLE 92. WERFEN : COMPANY SNAPSHOT
TABLE 93. WERFEN : OPERATING SEGMENTS
TABLE 94. WERFEN : PRODUCT PORTFOLIO
TABLE 95. WERFEN : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96. GRIFOLS, S.A. : KEY EXECUTIVES
TABLE 97. GRIFOLS, S.A. : COMPANY SNAPSHOT
TABLE 98. GRIFOLS, S.A. : OPERATING SEGMENTS
TABLE 99. GRIFOLS, S.A. : PRODUCT PORTFOLIO
TABLE 100. GRIFOLS, S.A. : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 102. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 103. DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 104. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 105. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. SIEMENS : KEY EXECUTIVES
TABLE 107. SIEMENS : COMPANY SNAPSHOT
TABLE 108. SIEMENS : OPERATING SEGMENTS
TABLE 109. SIEMENS : PRODUCT PORTFOLIO
TABLE 110. SIEMENS : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
TABLE 112. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 113. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
TABLE 114. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 115. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 116. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 117. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 118. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 119. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 120. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121. MERCK KGAA: KEY EXECUTIVES
TABLE 122. MERCK KGAA: COMPANY SNAPSHOT
TABLE 123. MERCK KGAA: OPERATING SEGMENTS
TABLE 124. MERCK KGAA: PRODUCT PORTFOLIO
TABLE 125. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 126. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES
TABLE 127. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
TABLE 128. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
TABLE 129. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
TABLE 130. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 131. CARDINAL HEALTH: KEY EXECUTIVES
TABLE 132. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 133. CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 134. CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 135. CARDINAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL IMMUNOHEMATOLOGY MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF IMMUNOHEMATOLOGY MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN IMMUNOHEMATOLOGY MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALIMMUNOHEMATOLOGY MARKET
FIGURE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SEGMENTATION, BY PRODUCT
FIGURE 11. IMMUNOHEMATOLOGY MARKET FOR ANALYZERS AND SYSTEMS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. IMMUNOHEMATOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL IMMUNOHEMATOLOGY MARKET SEGMENTATION, BY APPLICATION
FIGURE 14. IMMUNOHEMATOLOGY MARKET FOR BLOOD-RELATED DISEASES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. IMMUNOHEMATOLOGY MARKET FOR HIV, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. IMMUNOHEMATOLOGY MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. GLOBAL IMMUNOHEMATOLOGY MARKET SEGMENTATION, BY END USER
FIGURE 18. IMMUNOHEMATOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. IMMUNOHEMATOLOGY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. IMMUNOHEMATOLOGY MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 25. COMPETITIVE DASHBOARD
FIGURE 26. COMPETITIVE HEATMAP: IMMUNOHEMATOLOGY MARKET
FIGURE 27. TOP PLAYER POSITIONING, 2023
FIGURE 28. BIO-RAD LABORATORIES, INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 29. BIO-RAD LABORATORIES, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 30. BIO-RAD LABORATORIES, INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 31. WERFEN : NET SALES, 2021-2023 ($BILLION)
FIGURE 32. WERFEN : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. WERFEN : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. GRIFOLS, S.A. : NET SALES, 2021-2023 ($BILLION)
FIGURE 35. GRIFOLS, S.A. : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. GRIFOLS, S.A. : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. DANAHER CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. SIEMENS : NET SALES, 2021-2023 ($BILLION)
FIGURE 41. SIEMENS : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. SIEMENS : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. MERCK KGAA: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. MERCK KGAA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 55. CARDINAL HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 56. CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 57. CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
